文献速递泌尿生殖腹部MR

深度学习模拟增强MRI评估疑似前列腺癌

Deep Learning to Simulate Contrast-Enhanced MRI for Evaluating Suspected Prostate Cancer.
PubMed 文献 · Radiology · 2025-01-01

本研究回顾性纳入三个中心567例疑似前列腺癌男性患者,训练深度学习模型(pix2pix算法)从四个非增强MRI序列生成模拟增强MRI,并在内部及两个外部测试集评估。模拟与真实增强图像相似度高(多尺度结构相似指数内部测试集0.82、外部测试集1为0.71、外部测试集2为0.69),三位放射科医师基于PI-RADS v2.1评分一致性好(Cohen κ=0.96,95%CI:0.94,0.98)。将模拟增强图像加入双参数MRI后,323例中34例(10.5%)患者从PI-RADS 3升级为PI-RADS 4。

要点

  • 基于非增强MRI序列可深度学习生成模拟增强前列腺MRI。
  • 模拟与真实增强图像的多尺度结构相似指数在内部测试集为0.82。
  • 加入模拟增强图像后10.5%(34/323)患者PI-RADS评分由3升至4。

核心结论

  • 利用深度学习从非增强MRI生成模拟增强前列腺MRI是可行的,模拟与真实增强图像高度相似,基于PI-RADS v2.1评估临床显著前列腺癌的一致性极好。

研究设计与样本

  • 回顾性研究,纳入三个中心自2020年4月至2023年4月接受多参数MRI的疑似前列腺癌男性患者567例(平均年龄66岁±11[SD])。采用pix2pix算法,以动态对比增强序列第二期增强后相位为参考标准,从T1加权成像、T2加权成像、扩散加权成像和表观扩散系数图四个非增强序列训练生成模拟增强MRI。数据集分为训练测试集244例、内部测试集104例、外部测试集1 143例、外部测试集2 76例。

诊断标准与关键数值

  • 模拟与真实增强图像的相似度采用多尺度结构相似指数评估:内部测试集0.82、外部测试集1为0.71、外部测试集2为0.69。三位放射科医师独立使用PI-RADS v2.1对T2加权和扩散加权MRI联合模拟或真实增强图像进行评分,读者间一致性Cohen κ为0.96(95%CI:0.94,0.98)。将模拟增强图像加入双参数MRI后,323例患者中34例(10.5%)从PI-RADS 3升级为PI-RADS 4。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 外部测试集1的多尺度结构相似指数为0.71,外部测试集2为0.69,均低于内部测试集的0.82。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Multiparametric MRI, including contrast-enhanced sequences, is recommended for evaluating suspected prostate cancer, but concerns have been raised regarding potential contrast agent accumulation and toxicity. Purpose To evaluate the feasibility of generating simulated contrast-enhanced MRI from noncontrast MRI sequences using deep learning and to explore their potential value for assessing clinically significant prostate cancer using Prostate Imaging Reporting and Data System (PI-RADS) version 2.1. Materials and Methods Male patients with suspected prostate cancer who underwent multiparametric MRI were retrospectively included from three centers from April 2020 to April 2023. A deep learning model (pix2pix algorithm) was trained to synthesize contrast-enhanced MRI scans from four noncontrast MRI sequences (T1-weighted imaging, T2-weighted imaging, diffusion-weighted imaging, and apparent diffusion coefficient maps) and then tested on an internal and two external datasets. The reference standard for model training was the second postcontrast phase of the dynamic contrast-enhanced sequence. Similarity between simulated and acquired contrast-enhanced images was evaluated using the multiscale structural similarity index. Three radiologists independently scored T2-weighted and diffusion-weighted MRI with either simulated or acquired contrast-enhanced images using PI-RADS, version 2.1; agreement was assessed with Cohen κ. Results A total of 567 male patients (mean age, 66 years ± 11 [SD]) were divided into a training test set (n = 244), internal test set (n = 104), external test set 1 (n = 143), and external test set 2 (n = 76). Simulated and acquired contrast-enhanced images demonstrated high similarity (multiscale structural similarity index: 0.82, 0.71, and 0.69 for internal test set, external test set 1, and external test set 2, respectively) with excellent reader agreement of PI-RADS scores (Cohen κ, 0.96; 95% CI: 0.94, 0.98). When simulated contrast-enhanced imaging was added to biparametric MRI, 34 of 323 (10.5%) patients were upgraded to PI-RADS 4 from PI-RADS 3. Conclusion It was feasible to generate simulated contrast-enhanced prostate MRI using deep learning. The simulated and acquired contrast-enhanced MRI scans exhibited high similarity and demonstrated excellent agreement in assessing clinically significant prostate cancer based on PI-RADS, version 2.1. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Neji and Goh in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Huang H, Mo J, Ding Z, et al. Deep Learning to Simulate Contrast-Enhanced MRI for Evaluating Suspected Prostate Cancer. Radiology. 2025. PMID: 39807983. doi:10.1148/radiol.240238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。